Envista (NYSE:NVST) Stock Price Expected to Rise, Robert W. Baird Analyst Says

Envista (NYSE:NVST) had its price target raised by Robert W. Baird from $30.00 to $31.00 in a report released on Thursday, MarketBeat Ratings reports. The firm presently has an “outperform” rating on the stock. Robert W. Baird’s price target points to a potential upside of 27.76% from the stock’s current price.

Several other research firms have also recently commented on NVST. Citigroup began coverage on Envista in a research note on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price target for the company. William Blair upgraded Envista from a “hold” rating to an “outperform” rating in a research report on Friday, February 6th. Weiss Ratings upgraded Envista from a “sell (d)” rating to a “hold (c-)” rating in a research report on Tuesday, February 17th. Barclays increased their price objective on Envista from $24.00 to $34.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 11th. Finally, Leerink Partners set a $35.00 price objective on Envista and gave the stock an “outperform” rating in a research report on Friday, February 6th. Six research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, Envista currently has an average rating of “Hold” and an average price target of $28.83.

Envista Price Performance

Envista stock opened at $24.27 on Thursday. Envista has a 12 month low of $16.41 and a 12 month high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.04. The business has a 50 day simple moving average of $26.53 and a 200-day simple moving average of $24.06. The stock has a market capitalization of $3.95 billion, a PE ratio of 59.18, a price-to-earnings-growth ratio of 1.64 and a beta of 0.92.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.The business had revenue of $705.50 million during the quarter, compared to analysts’ expectations of $680.04 million. During the same quarter in the prior year, the business earned $0.24 earnings per share. The company’s quarterly revenue was up 14.4% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities analysts predict that Envista will post 1.42 earnings per share for the current year.

Insider Transactions at Envista

In other Envista news, SVP Mischa Reis sold 9,675 shares of the stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total value of $290,250.00. Following the completion of the transaction, the senior vice president owned 32,382 shares in the company, valued at approximately $971,460. This represents a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.99% of the company’s stock.

Institutional Trading of Envista

Several large investors have recently bought and sold shares of the company. Parallel Advisors LLC grew its holdings in Envista by 13.1% in the fourth quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock valued at $69,000 after purchasing an additional 367 shares during the last quarter. Bank of Montreal Can grew its holdings in Envista by 1.4% in the fourth quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock valued at $568,000 after purchasing an additional 372 shares during the last quarter. Sepio Capital LP grew its holdings in Envista by 1.2% in the fourth quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock valued at $687,000 after purchasing an additional 374 shares during the last quarter. Deutsche Bank AG grew its holdings in Envista by 2.9% in the fourth quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock valued at $378,000 after purchasing an additional 484 shares during the last quarter. Finally, State of Michigan Retirement System grew its holdings in Envista by 1.5% in the first quarter. State of Michigan Retirement System now owns 39,463 shares of the company’s stock valued at $1,001,000 after purchasing an additional 600 shares during the last quarter.

Key Headlines Impacting Envista

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Envista reported better-than-expected Q1 2026 results, with EPS of $0.36 versus the $0.31 consensus and revenue of $705.5 million versus $680.0 million expected, suggesting solid demand and execution. Envista (NYSE:NVST) Posts Better-Than-Expected Sales In Q1 CY2026
• Positive Sentiment: Management’s earnings transcript and presentation are likely reinforcing confidence in the turnaround and highlighting new growth drivers, which can support the stock if investors see improving fundamentals. Envista (NVST) Q1 2026 Earnings Transcript
• Positive Sentiment: Robert W. Baird raised its price target on Envista to $31 from $30 and kept an outperform rating, while JPMorgan lifted its target to $29 from $26, signaling improved analyst sentiment after the earnings beat.
• Positive Sentiment: Zacks highlighted Envista as a top long-term growth stock, which may help reinforce the market’s view that the company has attractive longer-term earnings potential. Why Envista (NVST) is a Top Growth Stock for the Long-Term
• Neutral Sentiment: Additional coverage on the Q1 earnings snapshot and key metrics is mostly informational, but it keeps the company in focus as investors assess whether the earnings beat is sustainable. Envista: Q1 Earnings Snapshot
• Neutral Sentiment: The stock still faces some caution because JPMorgan’s rating remained neutral despite the higher target, indicating analysts see upside but not a clear near-term rerating.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.